{
    "2019-01-11": [
        [
            {
                "time": "2019-01-01",
                "original_text": "NASH Space in Focus in 2019 as Firms Look to Diversify",
                "features": {
                    "keywords": [
                        "NASH",
                        "diversify"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2019-01-02",
                "original_text": "Will Tilrayâ€™s Dealmaking Lift Tilray Stock in 2019?",
                "features": {
                    "keywords": [
                        "Tilray",
                        "dealmaking"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "cannabis"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-01-03",
                "original_text": "Puma Biotech (PBYI) Down More Than 40% in 90 Days: Here's Why",
                "features": {
                    "keywords": [
                        "Puma Biotech",
                        "down",
                        "40%"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2019-01-04",
                "original_text": "Pharma Stock Roundup: Lilly to Buy Loxo for $8B, M&A in Focus at JP Morgan Meet",
                "features": {
                    "keywords": [
                        "Lilly",
                        "Loxo",
                        "M&A"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}